SCHEMBL30751302

SCHEMBL30751302

[2H]c1c([2H])c([2H])c(-n2cc(-c3cc(F)cc(CNC(=O)OC(C)(C)C)c3)cn2)c([2H])c1[2H]

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 1/20 0.37
▸ GRM2 Q14416 1/20 0.36
▸ CA1 P00915 3/20 0.35
▸ CA2 P00918 3/20 0.35
▸ CA9 Q16790 3/20 0.35
▸ CA12 O43570 2/20 0.35
▸ DYRK1A Q13627 2/20 0.34
▸ CA4 P22748 1/20 0.34
▸ CA7 P43166 1/20 0.34
▸ HDAC10 Q969S8 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ JAK2 O60674 1/20 0.33
▸ JAK1 P23458 1/20 0.33
▸ NAMPT P43490 2/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ PRMT5 O14744 1/20 0.32
▸ WDR77 Q9BQA1 1/20 0.32
▸ BRD4 O60885 1/20 0.32
▸ CREBBP Q92793 1/20 0.32
▸ GSK3B P49841 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31456992 1.00 MET (0.37) METGRM2CA1CA2CA9
SCHEMBL27375154 0.87 GRM2 (0.44) METGRM2CA1CA2CA9
SCHEMBL30751290 0.87 GRM2 (0.44) METGRM2CA1CA2CA9
SCHEMBL27375308 0.87 MET (0.38) METGRM2CA1CA2CA9
SCHEMBL30751300 0.87 MET (0.38) METGRM2CA1CA2CA9
SCHEMBL30751323 0.86 MET (0.46) METGRM2CA1CA2CA9
SCHEMBL31457042 0.86 MET (0.46) METGRM2CA1CA2CA9
SCHEMBL31456987 0.85 GRM2 (0.38) METGRM2CA1CA2CA9
SCHEMBL31457080 0.85 MAP4K4 (0.42) METGRM2CA1CA2CA9
SCHEMBL31456973 0.85 ADRB2 (0.44) METGRM2HDAC10HDAC6NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4567035-A1 NOVEL COMPOUND AS HYPOXIA-INDUCIBLE FACTOR 1(HIF-1) INHIBITOR OR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Nextgen Bioscience Co., Ltd. (KR) 2025-06-11 — — EP disclosed
WO-2024030000-A1 NOVEL COMPOUND AS HYPOXIA-INDUCIBLE FACTOR 1(HIF-1) INHIBITOR OR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 넥스트젠바이오사이언스 2024-02-08 — — WO disclosed
Send feedback